Tech Company Financing Transactions

Enterome Funding Round

Bristol-Myers Squibb, Health for Life Capital Fund and Lundbeckfond Ventures participated in a $38.6 million Series D capital raise for Enterome. This venture round was announced on 1/5/2018.

Transaction Overview

Company Name
Enterome
Announced On
1/5/2018
Transaction Type
Venture Equity
Amount
$38,633,920
Round
Series D
Investors

Bristol-Myers Squibb (Paul Biondi)

Health for Life Capital Fund

Lundbeckfond Ventures

Nestlé Health Science

OMNES Capital

Principia SGR (Paolo Siviero)

Seventure Partners (Isabelle de Cremoux)

Proceeds Purpose
The proceeds of the fundraising will be used primarily to progress two proof-of concept clinical trials of Enterome's lead development programs, a Phase 2 study of the Company's oral FimH blocker EB8018 for the treatment of Crohn's disease, and a Phase 1b study of EO2315, a novel immuno-oncology candidate, in patients with aggressive brain cancer (glioblastoma multiforme).

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 Bdwy. 14th Floor
Cambridge, MA 02142
USA
Phone
Undisclosed
Website
www.enterome.com
Email Address
[email protected]
Overview
Enterome is a company with the most advanced technology and products in the emerging field of disease management of the human gut microbiome.
Profile
Enterome LinkedIn Company Profile
Social Media
Enterome Company Twitter Account
Company News
Enterome News
Facebook
Enterome on Facebook
YouTube
Enterome on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Pierre Belichard
  Pierre Belichard LinkedIn Profile  Pierre Belichard Twitter Account  Pierre Belichard News  Pierre Belichard on Facebook
Chief Financial Officer
Christelle Dumoussaud
  Christelle Dumoussaud LinkedIn Profile  Christelle Dumoussaud Twitter Account  Christelle Dumoussaud News  Christelle Dumoussaud on Facebook
Chief Operating Officer
Marie-Laure Bouttier
  Marie-Laure Bouttier LinkedIn Profile  Marie-Laure Bouttier Twitter Account  Marie-Laure Bouttier News  Marie-Laure Bouttier on Facebook
Chief Scientific Officer
Chrictophe Bonny
  Chrictophe Bonny LinkedIn Profile  Chrictophe Bonny Twitter Account  Chrictophe Bonny News  Chrictophe Bonny on Facebook
VP - Bus. Development
Rodolphe Clerval
  Rodolphe Clerval LinkedIn Profile  Rodolphe Clerval Twitter Account  Rodolphe Clerval News  Rodolphe Clerval on Facebook

 

 

Browse more venture capital transactions:

Prev: 1/5/2018: Stoke Therapeutics venture capital transaction
Next: 1/5/2018: Cityblock Health venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

Our team works diligently to report on all VC transactions involving tech companies. VC investment data records on this site come from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.